London urged to pilot legal cannabis market

London is being urged to consider establishing its own pilot scheme to assess the potential benefits and risks of a regulated cannabis market. This follows a three-year legalisation pilot project in Switzerland, where recreational cannabis has been sold legally in pharmacies and dispensaries across major cities. The Swiss approach aims to manage the harms associated with cannabis use more effectively than leaving the market to criminal elements.

Current Policing Costs and Commission Recommendations

Read Next in News London3 min read

Mayor Sadiq Khan asks for extra funding for police, transport and housing

Khan presented three budget demands to the Chancellor after meeting Andy Burnham, citing rising rough sleeping and a need for greater devolution of finance

In London, authorities continue to spend substantial amounts of money policing a lucrative cannabis market that remains under the control of criminals. Data indicates that nearly one in ten adults in the capital consume cannabis, the highest proportion in any British region. Polling suggests that two-thirds of Londoners favour either legalising or decriminalising cannabis. An independent London Drugs Commission report, commissioned by Mayor Sadiq Khan, concluded last year that the "continuation of the law as it currently stands cannot be justified." The commission recommended partial decriminalisation, noting that prohibition "does little to prevent access to the drug" and disproportionately affects Black communities, creating a "pervasive sense of persecution."

The Swiss Pilot Project

Switzerland's nationwide effort to study different regulatory models for cannabis is providing insights into how loosening drug laws could function. In cities like Basel, cannabis has been sold legally for three years. Dispensaries, such as Grashaus in Basel, are designed to look more like lifestyle boutiques, offering quality-controlled products and information. Participants in these trials, like neuroscience student Esme, report benefits such as reduced anxiety and improved sleep. Esme stated that without the regulated study, she would likely purchase cannabis from street dealers, a prospect she finds concerning, particularly as a trans woman. She prefers the organic, strength-tested cannabis available through the legal channels.

Related Borough Coverage3 min read

Tory hopeful Alex Challoner proposes scrapping housing quotas

Businessman Alex Challoner claims his plans could unlock land for 300,000 new homes across London.

Adele Hollmann, scientific affairs manager at Sanity Group, the company behind Grashaus, emphasised that staff openly discuss that cannabis is not suitable for everyone. She noted that Switzerland has acknowledged the reality of cannabis use and is testing various models to determine the best regulatory approach. This ensures that adults who choose to use cannabis can access products with quality control and accurate information. Initial findings from these Swiss studies, which primarily involve existing cannabis consumers, suggest that legalisation may even lead to a reduction in overall cannabis use. Data from Grashaus indicates that most participants would purchase from legal sources if given the option, and many find staff advice on lower-risk use beneficial, with a significant decline in concurrent tobacco consumption.

Expert Calls for London Pilot

Experts, scientists, and politicians are advocating for London to emulate Switzerland by establishing its own pilot scheme. Such a scheme could assess the advantages and disadvantages of a regulated cannabis market. Legalisation could potentially generate billions in tax revenues over a decade, according to national projections. Countries like Canada and Germany, along with numerous US states, have already legalised recreational cannabis, indicating that London would not be venturing into entirely uncharted territory. Dr. Rayyan Zafar, a neuropsychopharmacologist at Imperial College London, supports the implementation of a "carefully designed legalisation pilot" because prohibition has failed to stop cannabis use and has hindered control over quality, potency, and consumer education. He cautions against adopting commercial models seen in some US states and Canadian provinces, suggesting a more cautious approach is warranted.

The Swiss pilot projects are authorised by the federal health office and involve recognised independent research institutes. Participants undergo screening, including urine tests, to ensure they are adults who already use cannabis, with the stated aim of not creating new consumers. Participants can be referred to doctors if issues arise, and so far, no psychiatric incidents linked to Grashaus have been reported. The trial offers a range of products, including lower-strength options, all grown to organic standards in Switzerland and lab-tested for THC content, which is capped at 20 per cent. The experiment is also insulated from commercial pressures, with no advertising permitted and sales restricted to registered participants.